💡 Key Takeaways
Table of Contents
Sulforaphane is associated with broccoli, sprouts, and the Nrf2 pathway. It also appears in very different headlines: some cautious, others clearly exaggerated. This article separates three things that are often conflated: what sulforaphane is, how it is formed, and what has actually been observed in human studies.
A compound that doesn't exist until we activate it
Sulforaphane is a sulfur-containing isothiocyanate produced in Brassicaceae family vegetables: broccoli, kale, cabbage, radish, watercress. Its peculiarity is that it is not present in the intact plant. It exists in a latent form as glucoraphanin, an inactive glucosinolate stored in cellular vacuoles.
Glucoraphanin and myrosinase —the enzyme that transforms it— are stored in separate compartments within the same cell. This is a defense mechanism: when something punctures the plant tissue, the two compounds come into contact and the reaction is triggered. In the field, this damage is caused by an insect. In the kitchen, we cause it by cutting or chewing.
Without that physical damage, there is no sulforaphane.
How sulforaphane is formed: glucoraphanin, myrosinase, and chewing
The conversion follows three steps: the plant tissue receives physical damage —cutting, chewing, crushing—, the myrosinase released from its compartment comes into contact with glucoraphanin and, within minutes, hydrolyzes it to produce active sulforaphane.
The reaction is fast, but the enzyme is fragile. Myrosinase is inactivated above approximately 70 °C. Boiling broccoli for more than three or four minutes destroys virtually all enzymatic activity. A study by Vermeulen et al. in Molecular Nutrition & Food Research (2008) measured the bioavailability of sulforaphane in people with raw versus cooked broccoli: availability was significantly higher with raw or lightly blanched vegetables.
Mustard offers a partial alternative for already cooked broccoli. It contains its own active myrosinase, which can partially compensate for enzyme loss. The effect is experimentally supported, although the amount of enzyme it provides varies depending on the type and quantity used.
When myrosinase is not available —due to cooking, industrial processing, or absence in the supplement—, conversion can partially occur through the gut microbiota. The problem is variability: the ability of each microbiome to hydrolyze glucosinolates differs among people. Two individuals taking the same glucoraphanin supplement can end up with very different levels of circulating sulforaphane.
Where it is found: sources and actual concentrations
Glucoraphanin is present in all cruciferous vegetables, but in very different concentrations. Broccoli is the most studied source and has the highest documented content.
| Source | Glucoraphanin (approx.) | Reference |
|---|---|---|
| Mature broccoli | 0.1–2.2 µmol/g fresh weight | Kushad et al., 1999 |
| Broccoli sprouts (3–5 days) | 10–100× more than mature broccoli | Fahey et al., PNAS 1997 |
| Broccoli microgreens (7–14 days) | High concentration, variable depending on cultivation | Bouranis et al., Foods 2023 |
| Kale | Present, lower than broccoli | — |
| Brussels sprouts | Present, moderate concentration | — |
| Radish | Present, mainly in root and leaves | — |
| Watercress | Present (predominant isothiocyanate: PEITC, different from sulforaphane) | — |
Variability within the same species is considerable. Kushad et al. (1999) analyzed 50 commercial broccoli varieties and found differences of up to 27 times between the poorest and the richest in glucoraphanin. The cultivation method, season, post-harvest storage, and time since harvest also affect the final content.
→ Detailed reading on this variability: Glucoraphanin in broccoli: variety, cultivation, and actual concentration
→ Why cruciferous vegetables are in a category of their own: Why cruciferous vegetables are different from other vegetables
How it acts in the body: the Nrf2 pathway
Once absorbed in the small intestine, sulforaphane reaches the cells and activates the Nrf2 pathway (Nuclear factor erythroid 2-related factor 2). Under normal conditions, Nrf2 remains sequestered in the cytoplasm, bound to the Keap1 protein. Sulforaphane modifies cysteine residues in Keap1, which releases Nrf2 and allows it to move to the cell nucleus.
Inside the nucleus, Nrf2 binds to antioxidant response elements (AREs) in the DNA and activates the transcription of more than 200 genes. Among them:
-
Phase II detoxification enzymes: glutathione S-transferases (GST), quinone oxidoreductase (NQO1), thioredoxin reductase.
-
γ-glutamylcysteine synthetase (GCLC), the rate-limiting step in glutathione production.
-
Heme oxygenase-1 (HO-1), with documented anti-inflammatory and cytoprotective effects.
Sulforaphane does not directly trap free radicals. What it does is induce the enzymatic systems responsible for it. Direct antioxidants have a punctual effect; Nrf2 inducers generate a sustained response for hours or days.
What the research says: humans, animals, and in vitro
The volume of publications on sulforaphane exceeds 3,000 entries in PubMed. Not all this evidence carries the same weight, and separating the levels is necessary to understand what is truly known.
| Level of evidence | What has been observed | Limitations |
|---|---|---|
| In vitro (cells) | Activates Nrf2, inhibits NF-κB, induces apoptosis in tumor cell lines | Doses used are not replicable with food; results do not predict effects in humans |
| Animal | Effects on inflammation, neuroprotection, and glucose metabolism in murine models | Extrapolation to humans is limited; metabolism and bioavailability differ |
| Human — observational | Cruciferous vegetable consumption associated with lower risk of some cancers in cohort studies | Association, not causation; results may be affected by other dietary habits |
| Human — clinical trials | Effects on markers of oxidative stress, inflammation, and fasting glucose in several studies | Small samples (20–150 people), short duration (4–12 weeks), heterogeneity of doses and formats |
A systematic review by Bahadoran et al. in Nutrition Reviews (2021) on the effects of sulforaphane on metabolic biomarkers concludes that the data are promising, but insufficient to establish formal clinical recommendations. Variability in bioavailability among individuals is one of the main obstacles to interpreting the results.
Basic mechanisms are well established in vitro and in animals. Human confirmation is progressing, but requires larger and longer trials.
Why not everyone absorbs the same amount
The amount of sulforaphane circulating in the blood after consuming a source of glucoraphanin depends on several factors.
Active myrosinase. When the enzyme has been destroyed by heat or industrial processing, conversion relies entirely on the gut microbiota. Studies with glucoraphanin supplements without myrosinase show plasma sulforaphane levels 3 to 10 times lower than those obtained with sources that retain the enzyme (Clarke et al., Cancer Prevention Research, 2011).
Microbiota composition. Variability among people in the ability of gut flora to hydrolyze glucosinolates is wide. Some individuals convert more than 40% of ingested glucoraphanin; others, less than 10% (Fahey et al., PLOS ONE, 2015).
Intestinal transit. Rapid transit reduces the contact time between glucoraphanin and colon bacteria, decreasing available conversion.
Physical form of the food. Thoroughly chewing raw vegetables maximizes myrosinase activation. A whole, uncrushed vegetable releases less than one that is well chewed or cut.
→ How food format changes actual absorption: Nutrient bioavailability: why you absorb 5% of some supplements?
What the evidence doesn't allow us to say
Health claims for sulforaphane have been reviewed by EFSA and have not been authorized in the EU claims register. This does not mean that the compound has no documented physiological effects. It means that the evidence available at the time of review did not meet the required level: causality demonstrated in humans with a robust design.
-
Mechanisms established in vitro and in animals: solid, well-replicated, published in high-impact journals.
-
Effects on human biomarkers: documented in several small trials, pending confirmation in larger-scale studies.
-
Direct clinical benefits (disease prevention, mortality reduction): not demonstrated to the level required for a regulatory claim.
Scientific interest is justified. Headlines that go beyond the evidence are not.
How to obtain sulforaphane practically
The pathway with the best documented bioavailability is the consumption of raw or lightly cooked cruciferous vegetables, with sufficient chewing for myrosinase to act.
Experimentally supported strategies:
-
Cut broccoli 40 minutes before cooking. Myrosinase activates part of the conversion before heat. Once formed, sulforaphane is more heat-stable than the enzyme that produces it.
-
Prefer short steaming or quick stir-frying. Steaming at moderate temperature preserves more enzymatic activity than boiling directly in water.
-
Add mustard to cooked broccoli. Provides active exogenous myrosinase that can partially compensate for loss during cooking.
-
Consume raw sprouts or microgreens. They concentrate glucoraphanin and preserve active myrosinase without any thermal processing.
For those seeking a concentrated and stable source without relying on culinary preparation, freeze-dried microgreens at low temperatures preserve both glucoraphanin and myrosinase in the original plant matrix. Freeze-drying removes water without destructive heat, which maintains intact enzymatic conversion capacity. This is what differentiates SYNERGIC from an industrialized extract: the precursor and the enzyme remain in their biological context, available to be activated in contact with saliva and the digestive environment.
→ Why the food format changes what the body absorbs: Sulforaphane: what it is, how it works, and why its whole food form is superior
Conclusion
Sulforaphane is a biochemically well-characterized compound. Its formation mechanism —glucoraphanin plus active myrosinase— explains why food preparation radically changes the available amount, and why the variability among people in circulating levels is so high.
Research in humans is promising. Biomarker studies show effects on oxidative stress, inflammation, and fasting glucose. But most are small and short-term, and have not reached the level of evidence required for a regulatory claim. This does not diminish the scientific interest in the compound; it simply places the discussion in its proper context.
The practical question is the same as for any other nutrient: the dose that circulates depends as much on the source as on the processing and the individual. Well-constructed nutrition considers both factors.
→ What is glucoraphanin, the precursor to sulforaphane: What is glucoraphanin? The precursor to sulforaphane explained
→ Differences between glucoraphanin and sulforaphane: Glucoraphanin vs. sulforaphane: why they are not the same
